GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD – RTT News


Monthly Prescribing Reference

GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD
RTT News
Arnuity Ellipta (fluticasone furoate inhalation powder) is a once-daily inhaled corticosteroid (ICS) medicine for the maintenance treatment of asthma. It is the first product in the Ellipta inhaler for the treatment of asthma to be introduced in the US
New Inhalers for Asthma, COPD LaunchedMonthly Prescribing Reference
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.Drug Discovery & Development
GSK expands its portfolio of medicines in the US for patients with asthma and SYS-CON Media (press release)

all 6 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.